$TDOC

Vandervoort Adam C sold $60K of TDOC

Vandervoort Adam C (CHIEF LEGAL OFFICER, SECRETARY) sold 7,906 shares of Teladoc Health, Inc. (TDOC) at $7.63 on 2026-06-02.

Original reporting
SEC EDGAR · Vandervoort Adam C
Published Jun 3, 2026, 8:25 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 3, 2026, 8:36 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$TDOC
Neutral
medium confidence
Mentioned
$TDOC
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TDOCNeutralLow
01

Why it matters

Traders may monitor for clustering of insider sales or subsequent disclosures, but this specific filing does not introduce new operational or financial information.

02

Market read

A disclosed insider sale can slightly influence sentiment, but without any accompanying corporate event, expected market impact is limited.

03

What to watch

No 10b5-1 plan is stated, but the filing alone doesn’t reveal reasons (taxes, diversification, personal liquidity) or whether other insiders are selling/buying concurrently.

Relevance 4/10Novelty 3/10Timing: SEC Form 4 filed June 3 (sale executed June 2)

Background

SEC Form 4 reports insider transactions by company officers/directors/10% owners; these filings are public but often not tied to new company fundamentals.

Company-level read

Ticker impact

$TDOCNeutralMedium confidence
Context

Teladoc Health insider Form 4 shows Chief Legal Officer sold 7,906 shares in an open-market transaction on June 2.

Expected impact

Low near-term impact; any reaction is likely sentiment-driven and short-lived.

Evidence & confidence

This is a routine SEC Form 4 insider transaction with no 10b5-1 plan and no accompanying company-specific event (earnings, guidance, deal, litigation).

Market effects

Minimal; single insider sale in a telehealth/healthcare IT name typically does not reset sector expectations.

None.

None.

Counterpoint

The sale may be routine liquidity/compensation-related rather than a bearish signal, especially given the modest dollar value versus typical institutional flows.

Key entities

  • Teladoc Health, Inc.

    TDOC insider transaction disclosure: Chief Legal Officer sold 7,906 shares at $7.6270 on June 2; Form 4 filed June 3.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$TDOCLow

Teladoc nabs insurance veteran as new CFO

Teladoc Health appointed Michael Grasher as its new CFO, effective immediately. Grasher succeeds Mala Murthy, who left in November. He brings over 30 years of experience in insurance and financial services, most recently as CFO of IFG Companies. The move follows Teladoc's recent revenue guidance reduction, partly due to challenges in its mental health unit, BetterHelp.

$TDOCMed

Teladoc appoints insurance executive Michael Grasher as CFO

Teladoc Health named Michael Grasher as its new CFO. Grasher, with over 30 years of experience in insurance, previously served as CFO of IFG Companies. The appointment follows Teladoc's recent revenue forecast cut and challenges in its mental health unit, BetterHelp. Analyst Elizabeth Anderson views the move positively for Teladoc's leadership.

$TDOCMedAI 8/10

Teladoc Health (TDOC) Q2 2026 Earnings Call Transcript

Teladoc Health (TDOC) reported Q2 2026 revenue of $606.9 million, down 4% year over year, with BetterHelp revenue $212.6 million, down 11% due to a faster shift from cash pay to insurance. Adjusted EBITDA was $65.7 million. Full-year 2026 guidance: revenue $2.36B to $2.45B and adjusted EBITDA $271M to $303M. CEO Charles Divita said insurance demand outpaced provider capacity.